SCP Vitalife Partners is a venture capital firm focused on life science investments in Israel and the U.S. With $230 million under management in two funds, SCP Vitalife has made more than 30 investments in life sciences start-ups. We invest in companies with break-through products that address a current medical need and that are protected by strong IP. Our team includes seasoned professionals with backgrounds as entrepreneurs, senior operating executives, clinical practitioners and technologists, providing hands-on assistance to our portfolio companies.
Deal activity and portfolio updates would appear here
Connect your data source to see recent transactions